Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 48
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Roopa Industries Ltd. engages in the manufacture of pharmaceutical products. Its products include triphenyl phosphine, glucosamine, and bromine and its derivatives. The company was founded on June 17, 1985 and is headquartered in Hyderabad, India.
Company Valuation
From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITD.
Data is available to registered users only
